BIO-B: the balance sheet

MyFinsight

For the quarter ending 2025-09-30, BIO-B has $9,696,400K in assets. $2,959,600K in debts. $395,800K in cash and cash equivalents.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-30
Cash and cash equivalents	395,800
Short-term investments	1,022,800
Accounts receivable, net	464,700
Inventory	783,200
Prepaid expenses	152,000
Other current assets	23,500
Total current assets	2,842,000
Property, plant and equipment, net	540,200
Operating lease right-of-use assets	180,300
Goodwill, net	578,700
Purchased intangibles, net	388,400
Other investments	5,057,800
Other assets	109,000
Assets	9,696,400

Accounts payable	128,800
Accrued payroll and employee benefits	182,800
Current maturities of long-term debt and notes payable	1,300
Income and other taxes payable	44,800
Current operating lease liabilities	36,800
Other current liabilities	127,800
Total current liabilities	522,300
Long-term debt, net of current maturities	1,201,400
Deferred income taxes	872,600
Operating lease liabilities	155,800
Other long-term liabilities	207,500
Total liabilities	2,959,600
Preferred stock, value, issued	0
Common stock-Common Class A	0
Common stock-Common Class B	0
Additional paid-in capital	461,900
Treasury stock-Treasury Stock Common	1,014,600
Retained earnings	7,456,300
Accumulated other comprehensive loss	-166,800
Total stockholders' equity	6,736,800
Total liabilities and stockholders' equity	9,696,400